ACT-AD a Media Partner for 10th Annual Drug Discovery for Neurodegeneration Conference
February 18, 2016 — ACT-AD is excited to be a media partner for the 10th Annual Drug Discovery for Neurodegeneration Conference to be held March 6-8 in Miami, Fla. Hosted by the Alzheimer’s Drug Discovery Foundation (ADDF), the conference “will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug.” It offers a comprehensive overview of the drug discovery process. For more information, please visit here.
ACT-AD is a coalition of more than 50 national organizations representing patients, providers, caregivers, consumers, older Americans, researchers, and employers seeking to accelerate development of potential cures and treatments for Alzheimer’s disease.